{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:43:23Z","timestamp":1773099803234,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH","award":["R01CA160514"],"award-info":[{"award-number":["R01CA160514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10911-026-09599-7","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:16:37Z","timestamp":1770362197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insights from Genomic Sequencing of Preclinical Breast Cancer Models Establish Human Parallels to Increase Therapeutic Applicability"],"prefix":"10.1007","volume":"31","author":[{"given":"Anthony J.","family":"Schulte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran R.","family":"Andrechek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"6797","key":"9599_CR1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, et al. Molecular Portraits of Human Breast Tumours. Nature. 2000;406(6797):747\u201352. https:\/\/doi.org\/10.1038\/35021093.","journal-title":"Nature"},{"issue":"19","key":"9599_CR2","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, et al. Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications. Proc Natl Acad Sci U S A. 2001;98(19):10869\u201374. https:\/\/doi.org\/10.1073\/pnas.191367098.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"9599_CR3","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, et al. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. J Clin Oncol. 2009;27(8):1160\u20137. https:\/\/doi.org\/10.1200\/JCO.2008.18.1370.","journal-title":"J Clin Oncol"},{"issue":"5","key":"9599_CR4","doi-asserted-by":"publisher","first-page":"R68","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat A, et al. Phenotypic and Molecular Characterization of the Claudin-Low Intrinsic Subtype of Breast Cancer. Breast Cancer Res. 2010;12(5):R68. https:\/\/doi.org\/10.1186\/bcr2635.","journal-title":"Breast Cancer Res"},{"issue":"7418","key":"9599_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive Molecular Portraits of Human Breast Tumours. Nature. 2012;490(7418):61\u201370. https:\/\/doi.org\/10.1038\/nature11412.","journal-title":"Nature"},{"issue":"2","key":"9599_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, et al. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015;163(2):506\u201319. https:\/\/doi.org\/10.1016\/j.cell.2015.09.033.","journal-title":"Cell"},{"issue":"5","key":"9599_CR7","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1158\/0008-5472.CAN-13-2779","volume":"74","author":"MJ Sikora","year":"2014","unstructured":"Sikora MJ, et al. Invasive Lobular Carcinoma Cell Lines are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen Response. Cancer Res. 2014;74(5):1463\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2779.","journal-title":"Cancer Res"},{"issue":"5","key":"9599_CR8","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","volume":"51","author":"HD Soule","year":"1973","unstructured":"Soule HD, Vazguez J, Long A, Albert S, Brennan M. A Human Cell Line from a Pleural Effusion Derived from a Breast Carcinoma. J Natl Cancer Inst. 1973;51(5):1409\u201316. https:\/\/doi.org\/10.1093\/jnci\/51.5.1409.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9599_CR9","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1093\/jnci\/52.5.1669","volume":"52","author":"L Ozzello","year":"1974","unstructured":"Ozzello L, Sordat B, Merenda C, Carrel S, Hurlimann J, Mach JP. Transplantation of a Human Mammary Carcinoma Cell Line (BT 20) Into Nude Mice. J Natl Cancer Inst. 1974;52(5):1669\u201372. https:\/\/doi.org\/10.1093\/jnci\/52.5.1669.","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"9599_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/jnci\/53.3.661","volume":"53","author":"R Cailleau","year":"1974","unstructured":"Cailleau R, Young R, Oliv\u00e9 M, Reeves WJ. Breast Tumor Cell Lines from Pleural Effusions. J Natl Cancer Inst. 1974;53(3):661\u201374. https:\/\/doi.org\/10.1093\/jnci\/53.3.661.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"9599_CR11","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/BF02616120","volume":"14","author":"R Cailleau","year":"1978","unstructured":"Cailleau R, Oliv\u00e9 M, Cruciger QV. Long-Term Human Breast Carcinoma Cell Lines of Metastatic Origin: Preliminary Characterization. In Vitro. 1978;14(11):911\u20135. https:\/\/doi.org\/10.1007\/BF02616120.","journal-title":"In Vitro"},{"key":"9599_CR12","doi-asserted-by":"publisher","unstructured":"Trempe GL. Human Breast Cancer in Culture. In: Recent Results Cancer Res. Fortschritte Krebsforsch. Progres Dans Rech. Sur Cancer, no. 57. 1976. p. 33\u201341. https:\/\/doi.org\/10.1007\/978-3-642-81043-5_5.","DOI":"10.1007\/978-3-642-81043-5_5"},{"issue":"2","key":"9599_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/bcr577","volume":"5","author":"SE Burdall","year":"2003","unstructured":"Burdall SE, Hanby AM, Lansdown MRJ, Speirs V. Breast Cancer Cell Lines: Friend or Foe? Breast Cancer Res BCR. 2003;5(2):89\u201395. https:\/\/doi.org\/10.1186\/bcr577.","journal-title":"Breast Cancer Res BCR"},{"issue":"1","key":"9599_CR14","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41467-019-10148-6","volume":"10","author":"K Liu","year":"2019","unstructured":"Liu K, et al. Evaluating Cell Lines as Models for Metastatic Breast Cancer Through Integrative Analysis of Genomic Data. Nat Commun. 2019;10(1):2138. https:\/\/doi.org\/10.1038\/s41467-019-10148-6.","journal-title":"Nat Commun"},{"issue":"39","key":"9599_CR15","doi-asserted-by":"publisher","first-page":"64289","DOI":"10.18632\/oncotarget.11733","volume":"7","author":"MC Abba","year":"2016","unstructured":"Abba MC, et al. DMBA Induced Mouse Mammary Tumors Display High Incidence of Activating Pik3caH1047 and Loss of Function Pten Mutations. Oncotarget. 2016;7(39):64289\u201399. https:\/\/doi.org\/10.18632\/oncotarget.11733.","journal-title":"Oncotarget"},{"issue":"2","key":"9599_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF01834643","volume":"20","author":"P Pazos","year":"1992","unstructured":"Pazos P, Lanari C, Meiss R, Charreau EH, Pasqualini CD. Mammary Carcinogenesis Induced by N-methyl-N-nitrosourea (MNU) and Medroxyprogesterone Acetate (MPA) in BALB\/c Mice. Breast Cancer Res Treat. 1992;20(2):133\u20138. https:\/\/doi.org\/10.1007\/BF01834643.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"9599_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.toxlet.2014.05.021","volume":"229","author":"MD Papaioannou","year":"2014","unstructured":"Papaioannou MD, Koufaris C, Gooderham NJ. The Cooked Meat-Derived Mammary Carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Elicits Estrogenic-Like MicroRNA Responses in Breast Cancer Cells. Toxicol Lett. 2014;229(1):9\u201316. https:\/\/doi.org\/10.1016\/j.toxlet.2014.05.021.","journal-title":"Toxicol Lett"},{"issue":"4","key":"9599_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10555-016-9653-x","volume":"35","author":"LE Dobrolecki","year":"2016","unstructured":"Dobrolecki LE, et al. Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research. Cancer Metastasis Rev. 2016;35(4):547\u201373. https:\/\/doi.org\/10.1007\/s10555-016-9653-x.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"9599_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(84)90257-5","volume":"38","author":"TA Stewart","year":"1984","unstructured":"Stewart TA, Pattengale PK, Leder P. Spontaneous Mammary Adenocarcinomas in Transgenic Mice that Carry and Express MTV\/myc Fusion Genes. Cell. 1984;38(3):627\u201337. https:\/\/doi.org\/10.1016\/0092-8674(84)90257-5.","journal-title":"Cell"},{"issue":"3","key":"9599_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/mcb.12.3.954-961.1992","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy CT, Cardiff RD, Muller WJ. Induction of Mammary Tumors by Expression of Polyomavirus Middle T Oncogene: a Transgenic Mouse Model for Metastatic Disease. Mol Cell Biol. 1992;12(3):954\u201361. https:\/\/doi.org\/10.1128\/mcb.12.3.954-961.1992.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"9599_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0092-8674(88)90184-5","volume":"54","author":"WJ Muller","year":"1988","unstructured":"Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P. Single-Step Induction of Mammary Adenocarcinoma in Transgenic Mice Bearing the Activated C-Neu Oncogene. Cell. 1988;54(1):105\u201315. https:\/\/doi.org\/10.1016\/0092-8674(88)90184-5.","journal-title":"Cell"},{"issue":"4","key":"9599_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0092-8674(87)90449-1","volume":"49","author":"E Sinn","year":"1987","unstructured":"Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV\/v-Ha-Ras and MMTV\/c-Myc Genes in Transgenic Mice: Synergistic Action of Oncogenes In Vivo. Cell. 1987;49(4):465\u201375. https:\/\/doi.org\/10.1016\/0092-8674(87)90449-1.","journal-title":"Cell"},{"issue":"6","key":"9599_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/1947601910378691","volume":"1","author":"J Xu","year":"2010","unstructured":"Xu J, Chen Y, Olopade OI. MYC and Breast Cancer. Genes Cancer. 2010;1(6):629\u201340. https:\/\/doi.org\/10.1177\/1947601910378691.","journal-title":"Genes Cancer"},{"issue":"38","key":"9599_CR24","doi-asserted-by":"publisher","first-page":"16387","DOI":"10.1073\/pnas.0901250106","volume":"106","author":"ER Andrechek","year":"2009","unstructured":"Andrechek ER, et al. Genetic Heterogeneity of Myc-Induced Mammary Tumors Reflecting Diverse Phenotypes Including Metastatic Potential. Proc Natl Acad Sci U S A. 2009;106(38):16387\u201392. https:\/\/doi.org\/10.1073\/pnas.0901250106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9599_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/84691","volume":"7","author":"CM D\u2019Cruz","year":"2001","unstructured":"D\u2019Cruz CM, et al. c-MYC Induces Mammary Tumorigenesis by Means of a Preferred Pathway Involving Spontaneous Kras2 Mutations. Nat Med. 2001;7(2):235\u20139. https:\/\/doi.org\/10.1038\/84691.","journal-title":"Nat Med"},{"issue":"1","key":"9599_CR26","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1038\/s41467-023-40841-6","volume":"14","author":"ZO Doha","year":"2023","unstructured":"Doha ZO, et al. MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer. Nat Commun. 2023;14(1):5665. https:\/\/doi.org\/10.1038\/s41467-023-40841-6.","journal-title":"Nat Commun"},{"issue":"2","key":"9599_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5858\/arpa.2012-0617-OA","volume":"138","author":"KA Schalper","year":"2014","unstructured":"Schalper KA, Kumar S, Hui P, Rimm DL, Gershkovich P. A Retrospective Population-Based Comparison of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization in Breast Carcinomas: Impact of 2007 American Society of Clinical Oncology\/ College of American Pathologists Criteria. Arch Pathol Lab Med. 2014;138(2):213\u20139. https:\/\/doi.org\/10.5858\/arpa.2012-0617-OA.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"9599_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0092-8674(89)90331-0","volume":"57","author":"L Bouchard","year":"1989","unstructured":"Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P. Stochastic Appearance of Mammary Tumors in Transgenic Mice Carrying the MMTV\/c-Neu Oncogene. Cell. 1989;57(6):931\u20136. https:\/\/doi.org\/10.1016\/0092-8674(89)90331-0.","journal-title":"Cell"},{"issue":"13","key":"9599_CR29","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1074\/jbc.271.13.7673","volume":"271","author":"CT Guy","year":"1996","unstructured":"Guy CT, Cardiff RD, Muller WJ. Activated Neu Induces Rapid Tumor Progression. J Biol Chem. 1996;271(13):7673\u20138. https:\/\/doi.org\/10.1074\/jbc.271.13.7673.","journal-title":"J Biol Chem"},{"issue":"7","key":"9599_CR30","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1073\/pnas.97.7.3444","volume":"97","author":"ER Andrechek","year":"2000","unstructured":"Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Amplification of the neu\/erbB-2 Oncogene in a Mouse Model of Mammary Tumorigenesis. Proc Natl Acad Sci U S A. 2000;97(7):3444\u20139. https:\/\/doi.org\/10.1073\/pnas.97.7.3444.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9599_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/sj.onc.1205146","volume":"21","author":"C Montagna","year":"2002","unstructured":"Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ, Ried T. Centrosome Abnormalities, Recurring Deletions of Chromosome 4, and Genomic Amplification of HER2\/neu Define Mouse Mammary Gland Adenocarcinomas Induced By Mutant HER2\/neu. Oncogene. 2002;21(6):890\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1205146.","journal-title":"Oncogene"},{"issue":"5","key":"9599_CR32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","volume":"163","author":"EY Lin","year":"2003","unstructured":"Lin EY, et al. Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases. Am J Pathol. 2003;163(5):2113\u201326. https:\/\/doi.org\/10.1016\/S0002-9440(10)63568-7.","journal-title":"Am J Pathol"},{"issue":"11","key":"9599_CR33","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/gb-2013-14-11-r125","volume":"14","author":"AD Pfefferle","year":"2013","unstructured":"Pfefferle AD, et al. Transcriptomic Classification of Genetically Engineered Mouse Models of Breast Cancer Identifies Human Subtype Counterparts. Genome Biol. 2013;14(11):R125. https:\/\/doi.org\/10.1186\/gb-2013-14-11-r125.","journal-title":"Genome Biol"},{"issue":"3","key":"9599_CR34","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41388-020-01560-0","volume":"40","author":"S Attalla","year":"2021","unstructured":"Attalla S, Taifour T, Bui T, Muller W. Insights from Transgenic Mouse Models of PyMT-Induced Breast Cancer: Recapitulating Human Breast Cancer Progression In Vivo. Oncogene. 2021;40(3):475\u201391. https:\/\/doi.org\/10.1038\/s41388-020-01560-0.","journal-title":"Oncogene"},{"issue":"1","key":"9599_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13058-022-01540-0","volume":"24","author":"N Deng","year":"2022","unstructured":"Deng N, et al. Deep Whole Genome Sequencing Identifies Recurrent Genomic Alterations in Commonly Used Breast Cancer Cell Lines and Patient-Derived Xenograft Models. Breast Cancer Res. 2022;24(1):63. https:\/\/doi.org\/10.1186\/s13058-022-01540-0.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"9599_CR36","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1101\/gr.231100.117","volume":"28","author":"M Nattestad","year":"2018","unstructured":"Nattestad M, et al. Complex Rearrangements and Oncogene Amplifications Revealed by Long-Read DNA and RNA Sequencing of a Breast Cancer Cell Line. Genome Res. 2018;28(8):1126\u201335. https:\/\/doi.org\/10.1101\/gr.231100.117.","journal-title":"Genome Res"},{"issue":"3","key":"9599_CR37","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr3672","volume":"16","author":"DP Hollern","year":"2014","unstructured":"Hollern DP, Andrechek ER. A Genomic Analysis of Mouse Models of Breast Cancer Reveals Molecular Features of Mouse Models and Relationships to Human Breast Cancer. Breast Cancer Res BCR. 2014;16(3):R59. https:\/\/doi.org\/10.1186\/bcr3672.","journal-title":"Breast Cancer Res BCR"},{"issue":"8","key":"9599_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PAI.0000000000000349","volume":"25","author":"WW Bivin","year":"2017","unstructured":"Bivin WW, Yergiyev O, Bunker ML, Silverman JF, Krishnamurti U. GRB7 Expression and Correlation with HER2 Amplification in Invasive Breast Carcinoma. Appl Immunohistochem Mol Morphol. 2017;25(8):553\u20138. https:\/\/doi.org\/10.1097\/PAI.0000000000000349.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"14","key":"9599_CR39","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1158\/0008-5472.CAN-12-3925","volume":"73","author":"B Schade","year":"2013","unstructured":"Schade B, et al. \u0392-Catenin Signaling is a Critical Event in ErbB2-Mediated Mammary Tumor Progression. Cancer Res. 2013;73(14):4474\u201387. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3925.","journal-title":"Cancer Res"},{"issue":"1","key":"9599_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10911-017-9374-y","volume":"22","author":"J Rennhack","year":"2017","unstructured":"Rennhack J, To B, Wermuth H, Andrechek ER. Mouse Models of Breast Cancer Share Amplification and Deletion Events with Human Breast Cancer. J Mammary Gland Biol Neoplasia. 2017;22(1):71\u201384. https:\/\/doi.org\/10.1007\/s10911-017-9374-y.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"9599_CR41","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1038\/s41467-019-11236-3","volume":"10","author":"JP Rennhack","year":"2019","unstructured":"Rennhack JP, et al. Integrated Analyses of Murine Breast Cancer Models Reveal Critical Parallels with Human Disease. Nat Commun. 2019;10(1):3261. https:\/\/doi.org\/10.1038\/s41467-019-11236-3.","journal-title":"Nat Commun"},{"issue":"20","key":"9599_CR42","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/onc.2011.433","volume":"31","author":"JY Leung","year":"2012","unstructured":"Leung JY, Andrechek ER, Cardiff RD, Nevins JR. Heterogeneity in MYC-Induced Mammary Tumors Contributes to Escape from Oncogene Dependence. Oncogene. 2012;31(20):2545\u201354. https:\/\/doi.org\/10.1038\/onc.2011.433.","journal-title":"Oncogene"},{"issue":"13","key":"9599_CR43","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1073\/pnas.0801197105","volume":"105","author":"K Podsypanina","year":"2008","unstructured":"Podsypanina K, Politi K, Beverly LJ, Varmus HE. Oncogene Cooperation in Tumor Maintenance and Tumor Recurrence in Mouse Mammary Tumors Induced by Myc and Mutant Kras. Proc Natl Acad Sci U S A. 2008;105(13):5242\u20137. https:\/\/doi.org\/10.1073\/pnas.0801197105.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9599_CR44","doi-asserted-by":"publisher","first-page":"e1007135","DOI":"10.1371\/journal.pgen.1007135","volume":"14","author":"DP Hollern","year":"2018","unstructured":"Hollern DP, Swiatnicki MR, Andrechek ER. Histological Subtypes of Mouse Mammary Tumors Reveal Conserved Relationships to Human Cancers. PLoS Genet. 2018;14(1):e1007135. https:\/\/doi.org\/10.1371\/journal.pgen.1007135.","journal-title":"PLoS Genet"},{"issue":"6","key":"9599_CR45","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.celrep.2019.06.098","volume":"28","author":"KM Campbell","year":"2019","unstructured":"Campbell KM, et al. A Spontaneous Aggressive ER\u03b1+ Mammary Tumor Model is Driven by Kras Activation. Cell Rep. 2019;28(6):1526-1537.e4. https:\/\/doi.org\/10.1016\/j.celrep.2019.06.098.","journal-title":"Cell Rep"},{"issue":"22","key":"9599_CR46","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.1158\/0008-5472.CAN-14-2992","volume":"75","author":"KL Wright","year":"2015","unstructured":"Wright KL, et al. Ras Signaling is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients. Cancer Res. 2015;75(22):4960\u201372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2992.","journal-title":"Cancer Res"},{"issue":"5","key":"9599_CR47","doi-asserted-by":"publisher","first-page":"e1008743","DOI":"10.1371\/journal.pgen.1008743","volume":"16","author":"C Ross","year":"2020","unstructured":"Ross C, et al. The Genomic Landscape of Metastasis in Treatment-Na\u00efve Breast Cancer Models. PLoS Genet. 2020;16(5):e1008743. https:\/\/doi.org\/10.1371\/journal.pgen.1008743.","journal-title":"PLoS Genet"},{"issue":"1","key":"9599_CR48","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13058-023-01723-3","volume":"25","author":"CD Broeker","year":"2023","unstructured":"Broeker CD, Ortiz MMO, Murillo MS. Integrative Multi-Omic Sequencing Reveals the MMTV-Myc Mouse Model Mimics Human Breast Cancer Heterogeneity. Breast Cancer Res. 2023;25(1):120. https:\/\/doi.org\/10.1186\/s13058-023-01723-3.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"9599_CR49","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1073\/pnas.1018862108","volume":"109","author":"JI Herschkowitz","year":"2012","unstructured":"Herschkowitz JI, et al. Comparative Oncogenomics Identifies Breast Tumors Enriched in Functional Tumor-Initiating Cells. Proc Natl Acad Sci U S A. 2012;109(8):2778\u201383. https:\/\/doi.org\/10.1073\/pnas.1018862108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"9599_CR50","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1242\/dmm.025239","volume":"9","author":"AD Pfefferle","year":"2016","unstructured":"Pfefferle AD, et al. Genomic Profiling of Murine Mammary Tumors Identifies Potential Personalized Drug Targets For p53-Deficient Mammary Cancers. Dis Model Mech. 2016;9(7):749\u201357. https:\/\/doi.org\/10.1242\/dmm.025239.","journal-title":"Dis Model Mech"},{"issue":"2","key":"9599_CR51","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/path.4517","volume":"236","author":"JC Francis","year":"2015","unstructured":"Francis JC, et al. Whole-Exome DNA Sequence Analysis of Brca2 - and Trp53 -Deficient Mouse Mammary Gland Tumours. J Pathol. 2015;236(2):186\u2013200. https:\/\/doi.org\/10.1002\/path.4517.","journal-title":"J Pathol"},{"issue":"1","key":"9599_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-018-5061-y","volume":"174","author":"DP Hollern","year":"2019","unstructured":"Hollern DP, et al. A Mouse Model Featuring Tissue-Specific Deletion of p53 and Brca1 Gives Rise to Mammary Tumors with Genomic and Transcriptomic Similarities to Human Basal-Like Breast Cancer. Breast Cancer Res Treat. 2019;174(1):143\u201355. https:\/\/doi.org\/10.1007\/s10549-018-5061-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"9599_CR53","doi-asserted-by":"publisher","first-page":"dmm037192","DOI":"10.1242\/dmm.037192","volume":"12","author":"AD Pfefferle","year":"2019","unstructured":"Pfefferle AD, Darr DB, Calhoun BC, Mott KR, Rosen JM, Perou CM. The MMTV-Wnt1 Murine Model Produces Two Phenotypically Distinct Subtypes of Mammary Tumors with Unique Therapeutic Responses to an EGFR Inhibitor. Dis Model Mech. 2019;12(7):dmm037192. https:\/\/doi.org\/10.1242\/dmm.037192.","journal-title":"Dis Model Mech"},{"issue":"1","key":"9599_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7150\/ijbs.65763","volume":"18","author":"JD Martinez","year":"2022","unstructured":"Martinez JD, Mo Q, Xu Y, Qin L, Li Y, Xu J. Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway. Int J Biol Sci. 2022;18(1):229\u201341. https:\/\/doi.org\/10.7150\/ijbs.65763.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"9599_CR55","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s42003-025-08624-5","volume":"8","author":"CR Ross","year":"2025","unstructured":"Ross CR, et al. Genetic Background and Oncogenic Driver Determines the Genomic Evolution and Transcriptomics of Mammary Tumor Metastasis. Commun Biol. 2025;8(1):1224. https:\/\/doi.org\/10.1038\/s42003-025-08624-5.","journal-title":"Commun Biol"},{"issue":"17","key":"9599_CR56","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1128\/MCB.00737-14","volume":"34","author":"DP Hollern","year":"2014","unstructured":"Hollern DP, Honeysett J, Cardiff RD, Andrechek ER. The E2F Transcription Factors Regulate Tumor Development and Metastasis in a Mouse Model of Metastatic Breast Cancer. Mol Cell Biol. 2014;34(17):3229\u201343. https:\/\/doi.org\/10.1128\/MCB.00737-14.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"9599_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/onc.2013.540","volume":"34","author":"ER Andrechek","year":"2015","unstructured":"Andrechek ER. HER2\/Neu Tumorigenesis and Metastasis is Regulated by E2F Activator Transcription Factors. Oncogene. 2015;34(2):217\u201325. https:\/\/doi.org\/10.1038\/onc.2013.540.","journal-title":"Oncogene"},{"issue":"5","key":"9599_CR58","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/0008-5472.CAN-10-2386","volume":"71","author":"K Fujiwara","year":"2011","unstructured":"Fujiwara K, Yuwanita I, Hollern DP, Andrechek ER. Prediction and Genetic Demonstration of a Role for Activator E2Fs in Myc-Induced Tumors. Cancer Res. 2011;71(5):1924\u201332. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2386.","journal-title":"Cancer Res"},{"issue":"10","key":"9599_CR59","doi-asserted-by":"publisher","first-page":"867","DOI":"10.18632\/oncoscience.259","volume":"2","author":"J Rennhack","year":"2015","unstructured":"Rennhack J, Andrechek E. Conserved E2F Mediated Metastasis in Mouse Models of Breast Cancer and HER2 Positive Patients. Oncoscience. 2015;2(10):867\u201371. https:\/\/doi.org\/10.18632\/oncoscience.259.","journal-title":"Oncoscience"},{"issue":"1","key":"9599_CR60","doi-asserted-by":"publisher","first-page":"10718","DOI":"10.1038\/s41598-019-47218-0","volume":"9","author":"DP Hollern","year":"2019","unstructured":"Hollern DP, et al. E2F1 Drives Breast Cancer Metastasis by Regulating the Target Gene FGF13 and Altering Cell Migration. Sci Rep. 2019;9(1):10718. https:\/\/doi.org\/10.1038\/s41598-019-47218-0.","journal-title":"Sci Rep"},{"issue":"1","key":"9599_CR61","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1038\/s41598-021-88924-y","volume":"11","author":"MR Swiatnicki","year":"2021","unstructured":"Swiatnicki MR, Andrechek ER. Metastasis is Altered Through Multiple Processes Regulated by the E2F1 Transcription Factor. Sci Rep. 2021;11(1):9502. https:\/\/doi.org\/10.1038\/s41598-021-88924-y.","journal-title":"Sci Rep"},{"issue":"46","key":"9599_CR62","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1038\/s41388-024-03172-4","volume":"43","author":"B To","year":"2024","unstructured":"To B, et al. Insight into Mammary Gland Development and Tumor Progression in an E2F5 Conditional Knockout Mouse Model. Oncogene. 2024;43(46):3402\u201315. https:\/\/doi.org\/10.1038\/s41388-024-03172-4.","journal-title":"Oncogene"},{"issue":"6","key":"9599_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ccr.2009.03.027","volume":"15","author":"S Liu","year":"2009","unstructured":"Liu S, et al. Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases. Cancer Cell. 2009;15(6):539\u201350. https:\/\/doi.org\/10.1016\/j.ccr.2009.03.027.","journal-title":"Cancer Cell"},{"issue":"11","key":"9599_CR64","doi-asserted-by":"publisher","first-page":"e20211743","DOI":"10.1084\/jem.20211743","volume":"220","author":"J Bhin","year":"2023","unstructured":"Bhin J, et al. MYC is a Clinically Significant Driver of mTOR Inhibitor Resistance in Breast Cancer. J Exp Med. 2023;220(11):e20211743. https:\/\/doi.org\/10.1084\/jem.20211743.","journal-title":"J Exp Med"},{"issue":"4","key":"9599_CR65","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.onc.1210664","volume":"27","author":"SJ Bultman","year":"2008","unstructured":"Bultman SJ, et al. Characterization of Mammary Tumors from Brg1 Heterozygous Mice. Oncogene. 2008;27(4):460\u20138. https:\/\/doi.org\/10.1038\/sj.onc.1210664.","journal-title":"Oncogene"},{"issue":"27","key":"9599_CR66","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1038\/onc.2011.486","volume":"31","author":"SE Franks","year":"2012","unstructured":"Franks SE, et al. Transgenic IGF-IR Overexpression Induces Mammary Tumors with Basal-Like Characteristics, Whereas IGF-IR-Independent Mammary Tumors Express a Claudin-Low Gene Signature. Oncogene. 2012;31(27):3298\u2013309. https:\/\/doi.org\/10.1038\/onc.2011.486.","journal-title":"Oncogene"},{"issue":"8","key":"9599_CR67","first-page":"1775","volume":"56","author":"D Gallahan","year":"1996","unstructured":"Gallahan D, et al. Expression of a Truncated Int3 Gene in Developing Secretory Mammary Epithelium Specifically Retards Lobular Differentiation Resulting in Tumorigenesis. Cancer Res. 1996;56(8):1775\u201385.","journal-title":"Cancer Res"},{"issue":"31","key":"9599_CR68","doi-asserted-by":"publisher","first-page":"12903","DOI":"10.1073\/pnas.0810402106","volume":"106","author":"MG Ponzo","year":"2009","unstructured":"Ponzo MG, et al. Met Induces Mammary Tumors with Diverse Histologies and is Associated with Poor Outcome and Human Basal Breast Cancer. Proc Natl Acad Sci U S A. 2009;106(31):12903\u20138. https:\/\/doi.org\/10.1073\/pnas.0810402106.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"9599_CR69","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1186\/bcr3321","volume":"14","author":"MJ Simmons","year":"2012","unstructured":"Simmons MJ, Serra R, Hermance N, Kelliher MA. NOTCH1 Inhibition In Vivo Results in Mammary Tumor Regression and Reduced Mammary Tumorsphere-Forming Activity In Vitro. Breast Cancer Res. 2012;14(5):R126. https:\/\/doi.org\/10.1186\/bcr3321.","journal-title":"Breast Cancer Res"},{"issue":"17","key":"9599_CR70","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1158\/0008-5472.CAN-09-1684","volume":"69","author":"JJ Ranger","year":"2009","unstructured":"Ranger JJ, Levy DE, Shahalizadeh S, Hallett M, Muller WJ. Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression. Cancer Res. 2009;69(17):6823\u201330. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1684.","journal-title":"Cancer Res"},{"issue":"1","key":"9599_CR71","doi-asserted-by":"publisher","first-page":"R16","DOI":"10.1186\/bcr3100","volume":"14","author":"SR Chan","year":"2012","unstructured":"Chan SR, et al. Stat1-Deficient Mice Spontaneously Develop Estrogen Receptor \u0391-Positive Luminal Mammary Carcinomas. Breast Cancer Res. 2012;14(1):R16. https:\/\/doi.org\/10.1186\/bcr3100.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"9599_CR72","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bbrc.2007.05.018","volume":"358","author":"A Hoshino","year":"2007","unstructured":"Hoshino A, Fujii H. Temporal Regulation of Stat5 Activity in Determination of Cell Differentiation Program. Biochem Biophys Res Commun. 2007;358(3):914\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.018.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9599_CR73","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li S, et al. Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts. Cell Rep. 2013;4(6):1116\u201330. https:\/\/doi.org\/10.1016\/j.celrep.2013.08.022.","journal-title":"Cell Rep"},{"issue":"2","key":"9599_CR74","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.molonc.2013.11.010","volume":"8","author":"S Du Manoir","year":"2014","unstructured":"Du Manoir S, et al. Breast Tumor PDXs are Genetically Plastic and Correspond to a Subset of Aggressive Cancers Prone to Relapse. Mol Oncol. 2014;8(2):431\u201343. https:\/\/doi.org\/10.1016\/j.molonc.2013.11.010.","journal-title":"Mol Oncol"},{"issue":"1","key":"9599_CR75","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cell.2016.08.041","volume":"167","author":"A Bruna","year":"2016","unstructured":"Bruna A, et al. A Biobank of Breast Cancer Explants with Preserved Intra-Tumor Heterogeneity to Screen Anticancer Compounds. Cell. 2016;167(1):260-274.e22. https:\/\/doi.org\/10.1016\/j.cell.2016.08.041.","journal-title":"Cell"},{"issue":"7291","key":"9599_CR76","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nature08989","volume":"464","author":"L Ding","year":"2010","unstructured":"Ding L, et al. Genome Remodelling in a Basal-Like Breast Cancer Metastasis and Xenograft. Nature. 2010;464(7291):999\u20131005. https:\/\/doi.org\/10.1038\/nature08989.","journal-title":"Nature"},{"issue":"11","key":"9599_CR77","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.2454","volume":"17","author":"YS DeRose","year":"2011","unstructured":"DeRose YS, et al. Tumor Grafts Derived from Women with Breast Cancer Authentically Reflect Tumor Pathology, Growth, Metastasis and Disease Outcomes. Nat Med. 2011;17(11):1514\u201320. https:\/\/doi.org\/10.1038\/nm.2454.","journal-title":"Nat Med"},{"issue":"2","key":"9599_CR78","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","volume":"3","author":"KP Guillen","year":"2022","unstructured":"Guillen KP, et al. A Human Breast Cancer-Derived Xenograft and Organoid Platform for Drug Discovery and Precision Oncology. Nat Cancer. 2022;3(2):232\u201350. https:\/\/doi.org\/10.1038\/s43018-022-00337-6.","journal-title":"Nat Cancer"},{"issue":"26","key":"9599_CR79","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1056\/NEJMra1307118","volume":"383","author":"HJ Burstein","year":"2020","unstructured":"Burstein HJ. Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. N Engl J Med. 2020;383(26):2557\u201370. https:\/\/doi.org\/10.1056\/NEJMra1307118.","journal-title":"N Engl J Med"},{"issue":"11","key":"9599_CR80","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, et al. Use of Chemotherapy Plus a Monoclonal Antibody Against HER2 for Metastatic Breast Cancer that Overexpresses HER2. N Engl J Med. 2001;344(11):783\u201392. https:\/\/doi.org\/10.1056\/NEJM200103153441101.","journal-title":"N Engl J Med"},{"issue":"2","key":"9599_CR81","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1535-6108(02)00097-1","volume":"2","author":"DB Agus","year":"2002","unstructured":"Agus DB, et al. Targeting Ligand-Activated ErbB2 Signaling Inhibits Breast and Prostate Tumor Growth. Cancer Cell. 2002;2(2):127\u201337. https:\/\/doi.org\/10.1016\/S1535-6108(02)00097-1.","journal-title":"Cancer Cell"},{"issue":"17","key":"9599_CR82","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1158\/1078-0432.CCR-16-2191","volume":"23","author":"X Xu","year":"2017","unstructured":"Xu X, et al. HER2 Reactivation Through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-Targeted Therapy in HER2+ Breast Cancer. Clin Cancer Res. 2017;23(17):5123\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2191.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"9599_CR83","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","volume":"20","author":"A Seidman","year":"2002","unstructured":"Seidman A, et al. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience. J Clin Oncol. 2002;20(5):1215\u201321. https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1215.","journal-title":"J Clin Oncol"},{"issue":"10","key":"9599_CR84","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.ejca.2005.04.006","volume":"41","author":"E Persohn","year":"2005","unstructured":"Persohn E, et al. Morphological and Morphometric Analysis of Paclitaxel and Docetaxel-Induced Peripheral Neuropathy in Rats. Eur J Cancer. 2005;41(10):1460\u20136. https:\/\/doi.org\/10.1016\/j.ejca.2005.04.006.","journal-title":"Eur J Cancer"},{"issue":"1","key":"9599_CR85","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13058-020-01354-y","volume":"22","author":"AC Garrido-Castro","year":"2020","unstructured":"Garrido-Castro AC, et al. Phase 2 Study of Buparlisib (BKM120), a Pan-Class I PI3K Inhibitor, in Patients with Metastatic Triple-Negative Breast Cancer. Breast Cancer Res. 2020;22(1):120. https:\/\/doi.org\/10.1186\/s13058-020-01354-y.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"9599_CR86","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.7150\/thno.68972","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, et al. Fgfr Blockade Boosts T Cell Infiltration into Triple-Negative Breast Cancer by Regulating Cancer-Associated Fibroblasts. Theranostics. 2022;12(10):4564\u201380. https:\/\/doi.org\/10.7150\/thno.68972.","journal-title":"Theranostics"},{"issue":"7035","key":"9599_CR87","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, et al. Specific Killing of BRCA2-Deficient Tumours with Inhibitors of Poly(ADP-Ribose) Polymerase. Nature. 2005;434(7035):913\u20137. https:\/\/doi.org\/10.1038\/nature03443.","journal-title":"Nature"},{"issue":"14","key":"9599_CR88","doi-asserted-by":"publisher","first-page":"E1301","DOI":"10.1073\/pnas.1210353110","volume":"110","author":"JF Knight","year":"2013","unstructured":"Knight JF, et al. Met Synergizes with p53 Loss to Induce Mammary Tumors that Possess Features of Claudin-Low Breast Cancer. Proc Natl Acad Sci U S A. 2013;110(14):E1301-1310. https:\/\/doi.org\/10.1073\/pnas.1210353110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9599_CR89","doi-asserted-by":"publisher","first-page":"e1010362","DOI":"10.1371\/journal.pgen.1010362","volume":"18","author":"MR Swiatnicki","year":"2022","unstructured":"Swiatnicki MR, et al. Elevated Phosphorylation of EGFR in NSCLC due to Mutations in PTPRH. PLoS Genet. 2022;18(9):e1010362. https:\/\/doi.org\/10.1371\/journal.pgen.1010362.","journal-title":"PLoS Genet"},{"issue":"10","key":"9599_CR90","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/onc.2012.142","volume":"32","author":"DP Hollern","year":"2013","unstructured":"Hollern DP, Yuwanita I, Andrechek ER. A Mouse Model with T58A Mutations in Myc Reduces the Dependence on KRas Mutations and has Similarities to Claudin-Low Human Breast Cancer. Oncogene. 2013;32(10):1296\u2013304. https:\/\/doi.org\/10.1038\/onc.2012.142.","journal-title":"Oncogene"},{"issue":"10","key":"9599_CR91","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41388-022-02586-2","volume":"42","author":"E Henriet","year":"2023","unstructured":"Henriet E, et al. Triple Negative Breast Tumors Contain Heterogeneous Cancer Cells Expressing Distinct KRAS-Dependent Collective and Disseminative Invasion Programs. Oncogene. 2023;42(10):737\u201347. https:\/\/doi.org\/10.1038\/s41388-022-02586-2.","journal-title":"Oncogene"},{"issue":"7074","key":"9599_CR92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, et al. Oncogenic Pathway Signatures in Human Cancers as a Guide to Targeted Therapies. Nature. 2006;439(7074):353\u20137. https:\/\/doi.org\/10.1038\/nature04296.","journal-title":"Nature"},{"issue":"2","key":"9599_CR93","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2204619","volume":"387","author":"PA J\u00e4nne","year":"2022","unstructured":"J\u00e4nne PA, et al. Adagrasib in Non\u2013Small-Cell Lung Cancer Harboring a KRASG12C Mutation. N Engl J Med. 2022;387(2):120\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2204619.","journal-title":"N Engl J Med"},{"issue":"25","key":"9599_CR94","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","volume":"384","author":"F Skoulidis","year":"2021","unstructured":"Skoulidis F, et al. Sotorasib for Lung Cancers with KRAS p. G12C Mutation. N Engl J Med. 2021;384(25):2371\u201381. https:\/\/doi.org\/10.1056\/NEJMoa2103695.","journal-title":"N Engl J Med"},{"issue":"8013","key":"9599_CR95","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41586-024-07205-6","volume":"629","author":"M Holderfield","year":"2024","unstructured":"Holderfield M, et al. Concurrent Inhibition of Oncogenic and Wild-Type RAS-GTP for Cancer Therapy. Nature. 2024;629(8013):919\u201326. https:\/\/doi.org\/10.1038\/s41586-024-07205-6.","journal-title":"Nature"},{"issue":"1","key":"9599_CR96","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41467-023-37537-2","volume":"14","author":"P Ter Brugge","year":"2023","unstructured":"Ter Brugge P, et al. Homologous Recombination Deficiency Derived from Whole-Genome Sequencing Predicts Platinum Response in Triple-Negative Breast Cancers. Nat Commun. 2023;14(1):1958. https:\/\/doi.org\/10.1038\/s41467-023-37537-2.","journal-title":"Nat Commun"},{"issue":"4","key":"9599_CR97","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.7150\/thno.36182","volume":"10","author":"F Coussy","year":"2020","unstructured":"Coussy F, et al. Response to mTOR and PI3K Inhibitors in Enzalutamide-Resistant Luminal Androgen Receptor Triple-Negative Breast Cancer Patient-Derived Xenografts. Theranostics. 2020;10(4):1531\u201343. https:\/\/doi.org\/10.7150\/thno.36182.","journal-title":"Theranostics"},{"issue":"5","key":"9599_CR98","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2015.04.004","volume":"161","author":"DG Lupi\u00e1\u00f1ez","year":"2015","unstructured":"Lupi\u00e1\u00f1ez DG, et al. Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions. Cell. 2015;161(5):1012\u201325. https:\/\/doi.org\/10.1016\/j.cell.2015.04.004.","journal-title":"Cell"},{"issue":"1","key":"9599_CR99","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13073-022-01073-3","volume":"14","author":"JM Ellingford","year":"2022","unstructured":"Ellingford JM, et al. Recommendations for Clinical Interpretation of Variants Found in Non-Coding Regions of the Genome. Genome Med. 2022;14(1):73. https:\/\/doi.org\/10.1186\/s13073-022-01073-3.","journal-title":"Genome Med"},{"issue":"2","key":"9599_CR100","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.celrep.2019.08.105","volume":"29","author":"A Hirukawa","year":"2019","unstructured":"Hirukawa A, et al. Reduction of Global H3K27me3 Enhances HER2\/ErbB2 Targeted Therapy. Cell Rep. 2019;29(2):249-257.e8. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.105.","journal-title":"Cell Rep"},{"issue":"1","key":"9599_CR101","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Spatial Transcriptomics Reveals Substantial Heterogeneity in Triple-Negative Breast Cancer with Potential Clinical Implications. Nat Commun. 2024;15(1):10232. https:\/\/doi.org\/10.1038\/s41467-024-54145-w.","journal-title":"Nat Commun"},{"issue":"4","key":"9599_CR102","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.trecan.2020.12.006","volume":"7","author":"C Gnann","year":"2021","unstructured":"Gnann C, Cesnik AJ, Lundberg E. Illuminating Non-Genetic Cellular Heterogeneity with Imaging-Based Spatial Proteomics. Trends Cancer. 2021;7(4):278\u201382. https:\/\/doi.org\/10.1016\/j.trecan.2020.12.006.","journal-title":"Trends Cancer"},{"key":"9599_CR103","doi-asserted-by":"publisher","unstructured":"McFadden DG, et al. Mutational Landscape of EGFR- , MYC- , and Kras- Driven Genetically Engineered Mouse Models of Lung Adenocarcinoma. Proc Natl Acad Sci. 2016;113(42). https:\/\/doi.org\/10.1073\/pnas.1613601113.","DOI":"10.1073\/pnas.1613601113"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-026-09599-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09599-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:03:37Z","timestamp":1773061417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-026-09599-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9599"],"URL":"https:\/\/doi.org\/10.1007\/s10911-026-09599-7","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7"}}